Consistent with the notion that DAAM1 inhibits and DAAM2 promotes ACM-induced BCC migration (Fig. 9j), decreased expression of DAAM1 in breast cancer patients resulted in a significant reduction in survival (Supplementary Fig. 10i). This evidence concerns the gene DAAM2 and skin basal cell carcinoma.